Dr. Reddy's Laboratories
RDY
#1841
Rank
NZ$18.70 B
Marketcap
NZ$22.28
Share price
1.13%
Change (1 day)
-9.61%
Change (1 year)

Earnings for Dr. Reddy's Laboratories (RDY)

Earnings in 2025 (TTM): NZ$1.58 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's current earnings are NZ$3.95 Billion. In 2024 the company made an earning of NZ$1.49 Billion, an increase over its 2023 earnings that were of NZ$1.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dr. Reddy's Laboratories from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$1.58 B6.4%
2024 NZ$1.49 B7.01%
2023 NZ$1.39 B17.62%
2022 NZ$1.18 B43.27%
2021 NZ$0.82 B31.44%
2020 NZ$0.62 B54.54%
2019 NZ$0.40 B-14.21%
2018 NZ$0.47 B26.15%
2017 NZ$0.37 B4.69%
2016 NZ$0.35 B-55.7%
2015 NZ$0.81 B1.83%
2014 NZ$0.79 B-3.78%
2013 NZ$0.82 B54.07%
2012 NZ$0.53 B-16.23%
2011 NZ$0.64 B56.66%
2010 NZ$0.40 B-235.36%
2009 -NZ$0.31 Billion-198.53%
2008 NZ$0.30 B30.77%
2007 NZ$0.23 B-14.61%
2006 NZ$0.27 B703.63%
2005 NZ$34.19 M649.45%
2004 NZ$4.56 M-95.68%
2003 NZ$0.10 B-14.86%
2002 NZ$0.12 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
NZ$27.26 B 1,686.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$19.67 B 1,189.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$15.11 B 890.26%๐Ÿ‡ซ๐Ÿ‡ท France
GSK plc
GSK
NZ$15.47 B 914.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$2.94 B 92.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel